New dengue vaccine successfully tested in Phase 1 trial

Unisanté has conducted a clinical study of a new vaccine to combat dengue fever. 26 participants aged 18 to 45 were vaccinated in Lausanne in 2021, and followed for six months untilʹMarch 2022. This small-scale test monitored their immune response and any side effects resulting from the vaccine. The results of the study are rather encouraging